Related Experiment Video
Updated: Jun 17, 2025
10:07
High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
Published on: January 27, 2013
15.0K
Tick-Derived Peptide Blocks Potassium Channel TREK-1
Canwei Du1,2, Linyan Chen2, Guohao Liu1
1School of Life and Health Sciences, Hunan University of Science and Technology, Xiangtan 411201, China.
International Journal of Molecular Sciences
|August 10, 2024
Summary
A novel tick peptide, IstTx, selectively inhibits the TREK-1 potassium channel. This discovery offers a new tool for understanding tick-borne diseases and their mechanisms.
Area of Science:
- Biochemistry
- Molecular Biology
- Parasitology
Background:
- Ticks transmit pathogens, causing diseases in humans and animals.
- Tick saliva contains bioactive compounds that aid blood feeding and disease transmission.
Purpose of the Study:
- To analyze a novel peptide, IstTx, from Ixodes scapularis.
- To investigate the functional role of IstTx on ion channels.
- To explore IstTx as a potential tool for studying tick-borne diseases.
Main Methods:
- Recombinant expression and purification of IstTx peptide.
- Potassium channel inhibition assays to determine IC50 values.
- Molecular docking to predict peptide-channel interactions.
- Investigating the effect of extracellular acidification on channel inhibition.
Main Results:
- IstTx selectively inhibited the TREK-1 potassium channel in a dose-dependent manner (IC50 = 23.46 ± 0.22 μM).
- IstTx demonstrated distinct characteristics compared to fluoxetine.
- Molecular docking suggested a potential binding interaction between IstTx and TREK-1.
- Extracellular acidification enhanced IstTx's inhibitory effect on TREK-1.
Conclusions:
- The tick-derived peptide IstTx effectively blocks the TREK-1 potassium channel.
- IstTx represents a novel molecular tool for research on potassium channels and tick-borne disease mechanisms.
Related Concept Videos
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
941
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
941
01:28Depolarizing Blockers: Mechanism of Action
1.5K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.5K
01:19Depolarizing Blockers: Pharmocokinetics
316
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
316
01:24Non-gated Ion Channels
6.8K
Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
6.8K
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K
01:20Antiepileptic Drugs: Potassium Channel Activators
152
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
152